IRadimed Valuation
| 46K Stock | EUR 89.50 3.00 3.47% |
At this time, the firm appears to be overvalued. IRadimed retains a regular Real Value of €74.39 per share. The prevalent price of the firm is €89.5. Our model calculates the value of IRadimed from examining the firm fundamentals such as Return On Equity of 0.18, current valuation of 288.03 M, and Return On Asset of 0.12 as well as evaluating its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that IRadimed's price fluctuation is very steady at this time. Calculation of the real value of IRadimed is based on 3 months time horizon. Increasing IRadimed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the IRadimed stock is determined by what a typical buyer is willing to pay for full or partial control of IRadimed. Since IRadimed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IRadimed Stock. However, IRadimed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 89.5 | Real 74.39 | Hype 86.5 |
The real value of IRadimed Stock, also known as its intrinsic value, is the underlying worth of IRadimed Company, which is reflected in its stock price. It is based on IRadimed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of IRadimed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of IRadimed helps investors to forecast how IRadimed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IRadimed more accurately as focusing exclusively on IRadimed's fundamentals will not take into account other important factors: IRadimed Total Value Analysis
IRadimed is presently estimated to have takeover price of 288.03 M with market capitalization of 449.87 M, debt of 2.61 M, and cash on hands of 56.11 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the IRadimed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
288.03 M | 449.87 M | 2.61 M | 56.11 M |
IRadimed Investor Information
About 44.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 452.94. IRadimed last dividend was issued on the 10th of February 2023. Based on the measurements of operating efficiency obtained from IRadimed's historical financial statements, IRadimed is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.IRadimed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. IRadimed has an asset utilization ratio of 62.33 percent. This implies that the Company is making €0.62 for each dollar of assets. An increasing asset utilization means that IRadimed is more efficient with each dollar of assets it utilizes for everyday operations.IRadimed Ownership Allocation
The market capitalization of IRadimed is €449.87 Million. IRadimed secures large amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.IRadimed Profitability Analysis
The company reported the revenue of 53.3 M. Net Income was 12.83 M with profit before overhead, payroll, taxes, and interest of 41.28 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates IRadimed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in IRadimed and how it compares across the competition.
About IRadimed Valuation
The stock valuation mechanism determines IRadimed's current worth on a weekly basis. Our valuation model uses a comparative analysis of IRadimed. We calculate exposure to IRadimed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IRadimed's related companies.IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devices, and related accessories and services in the United States and internationally. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida. IRADIMED CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 110 people.
8 Steps to conduct IRadimed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates IRadimed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct IRadimed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain IRadimed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine IRadimed's revenue streams: Identify IRadimed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research IRadimed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish IRadimed's growth potential: Evaluate IRadimed's management, business model, and growth potential.
- Determine IRadimed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate IRadimed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for IRadimed Stock analysis
When running IRadimed's price analysis, check to measure IRadimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRadimed is operating at the current time. Most of IRadimed's value examination focuses on studying past and present price action to predict the probability of IRadimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRadimed's price. Additionally, you may evaluate how the addition of IRadimed to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |